Changes in outer membrane proteins of nontypable Haemophilus influenzae in patients with chronic obstructive

K Groeneveld1, L van Alphen, P P Eijk

  • 1Department of Medical Microbiology, University of Amsterdam, The Netherlands.

Insights

Haemophilus influenzae major outer membrane proteins (MOMPs) change in chronic obstructive pulmonary disease (COPD) patients. These MOMP variations may help the bacteria evade immune defenses during persistent infections.

Area of Science:

  • Microbiology
  • Immunology
  • Pulmonary Medicine

Background:

  • Haemophilus influenzae is a common pathogen in chronic obstructive pulmonary disease (COPD).
  • Bacterial outer membrane proteins play a crucial role in host-pathogen interactions and immune evasion.
  • Understanding changes in these proteins during chronic infection is vital for developing effective treatments.

Purpose of the Study:

  • To investigate alterations in major outer membrane proteins (MOMPs) of Haemophilus influenzae during persistent colonization in COPD patients.
  • To determine if changes in MOMPs correlate with bacterial strain relatedness.

Main Methods:

  • Sputum samples from 18 COPD patients were cultured to isolate Haemophilus influenzae colonies.
  • Chromosomal DNA fingerprinting was used to analyze the genetic relatedness of bacterial isolates.
  • Major outer membrane protein (MOMP) profiles of the isolates were analyzed and compared.

Main Results:

  • Isolates from the same patient often exhibited different MOMP compositions.
  • Chromosomal DNA fingerprints were identical for isolates with the same MOMP composition but different for those with varying MOMPs.
  • In seven patients, distinct MOMP variants were identified within genetically indistinguishable strains, specifically affecting proteins b, c, and d.

Conclusions:

  • Haemophilus influenzae demonstrates significant variability in its major outer membrane proteins (MOMPs) within individual COPD patients.
  • These MOMP changes are likely an adaptive mechanism for immune evasion, contributing to persistent infections.
  • Further research into these antigenic variations could inform novel therapeutic strategies for COPD exacerbations.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...